The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980. It was the first journal established in the United States to focus on psychoactive drug use, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally-relevant substance abuse treatment. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.740.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Journal of Psychoactive Drugs (en)
|
rdfs:comment
| - The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980. It was the first journal established in the United States to focus on psychoactive drug use, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally-relevant substance abuse treatment. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.740. (en)
|
foaf:name
| - Journal of Psychoactive Drugs (en)
|
foaf:homepage
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
impact
| |
abbreviation
| |
discipline
| |
former name
| - Journal of Psychedelic Drugs (en)
|
history
| |
ISSN
| |
language
| |
publisher
| |
title
| - Journal of Psychoactive Drugs (en)
|
website
| |
has abstract
| - The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980. It was the first journal established in the United States to focus on psychoactive drug use, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally-relevant substance abuse treatment. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.740. (en)
|
eISSN
| |
impact-year
| |
impact factor
| |
impact factor as of
| |
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
abbreviation
| |
first publication year
| |
issn
| |
academic discipline
| |
publisher
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |